What is the Y-tunnus number of Multifokaalinen Oy?

Multifokaalinen Oy is registered with PRH / YTJ under Y-tunnus 2945568-2.

What is the revenue of Multifokaalinen Oy?

Multifokaalinen Oy reported revenue of EUR 366K in 2024.

How many employees does Multifokaalinen Oy have?

Multifokaalinen Oy employs 2 people as of the latest annual report.

Who is the CEO of Multifokaalinen Oy?

Samuel Matias Kauranen is Deputy Member of Multifokaalinen Oy, in role since 2018.

Who is the chairman of Multifokaalinen Oy?

Mikael Henrik Kauranen chairs the board of Multifokaalinen Oy, in role since 2018.

Where is Multifokaalinen Oy headquartered?

Multifokaalinen Oy's registered address is Halsuantie 12-F22.

Multifokaalinen Oy

OYDissolved

Y-tunnus 2945568-2Halsuantie 12-F22Medical specialists activities · NACE 8622Est. 20182 employees

Revenue 2024

EUR 366K

+9% vs 2023

EBITDA margin

39.7%

-9% vs 2023

Equity ratio

97.6%

Financial strength

Net profit 2024

EUR 112K

-9% vs 2023

EBITDA — year on yearEUR millions

Key figuresAnnual report 2024

Revenue	EUR 366K	+9%
EBITDA	EUR 145K	-9%
Net profit	EUR 112K	-9%
Total assets	EUR 572K	+8%
Equity	EUR 559K	+15%
Employees	2	—

Item	2020	2021	2022	2023	2024
Revenue	258	298	328	335	366
Staff expenses	−81	−117	−125	−142	−141
EBITDA	148	143	178	160	145
Depreciation & amort.	−8	−6	−5	−4	−3
EBIT	140	137	173	156	142
Net financials	−2	−4	−2	−2	−2
Profit before tax	138	133	171	153	140
Tax	30	24	34	31	28
Net profit	108	109	137	123	112

Item	2020	2021	2022	2023	2024
Total assets	263	331	468	531	572
Equity	180	275	392	485	559
Long-term debt	—	—	—	0	0
Short-term debt	83	56	76	46	14
Total debt	83	56	76	46	14

Name	Role	Member since
Current (1)
SM Samuel Matias Kauranen Deputy Member	Deputy Member	2018

Name	Role	Member since
Current (1)
MH Mikael Henrik Kauranen	Board of Directors	2018

Person	Role here	Other companies
Samuel Matias Kauranen	Deputy Member	0 companies
Mikael Henrik Kauranen	Board of Directors	0 companies

Multifokaalinen Oy

OYDissolved

Y-tunnus 2945568-2Halsuantie 12-F22Medical specialists activities · NACE 8622Est. 20182 employees

Revenue 2024

EUR 366K

+9% vs 2023

EBITDA margin

39.7%

-9% vs 2023

Equity ratio

97.6%

Financial strength

Net profit 2024

EUR 112K

-9% vs 2023

EBITDA — year on yearEUR millions

Key figuresAnnual report 2024

Revenue	EUR 366K	+9%
EBITDA	EUR 145K	-9%
Net profit	EUR 112K	-9%
Total assets	EUR 572K	+8%
Equity	EUR 559K	+15%
Employees	2	—